EPCAM and non-small cell lung carcinoma: Analysis of gene expression in patients’ CTCs revealed that all patients expressed EpCAM and ALDH1A1, while CD133 was detected in 50%, Bmi1 in 80%, and Twist1 in 40% of patients, confirming the presence of both EMT and CSC markers in NSCLC.